Average Co-Inventor Count = 3.79
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Zymogenetics, Inc. (28 from 723 patents)
2. The Dow Chemical Company (6 from 7,680 patents)
3. Bristol-myers Squibb Compnay (6 from 3,684 patents)
4. Alpine Immune Sciences, Inc. (3 from 24 patents)
5. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
43 patents:
1. 12304943 - April and BAFF inhibitory immunomodulatory proteins and methods of use thereof
2. 12202882 - APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof
3. 11274140 - APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof
4. 11254740 - Methods of treatment using IL-23p19 monoclonal antibodies
5. 10570187 - Soluble hybrid Fcγ receptors and related methods
6. 10358489 - IL-23p19 monoclonal antibodies
7. 10358490 - Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies
8. 9783606 - Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies
9. 9708401 - IL-17A/F cross-reactive monoclonal antibodies and methods of using the same
10. 9663566 - Soluble hybrid Fcγ receptors and related methods
11. 9346878 - Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins
12. 8945553 - Bispecific antibodies to IL-23 and IL-17A/F
13. 8815238 - Methods for Preparing TACI-immunoglobulin fusion proteins
14. 8658766 - Soluble hybrid Fcγ receptors and related methods
15. 8524232 - Methods of treatment using taci-immunoglobulin fusion proteins